文献速递肝病

使用他汀类药物与酒精性肝硬化患者失代偿和死亡风险降低相关:一项全国性病例队列研究

Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2017-01-01

基于丹麦登记数据1995至2014年的回顾性病例队列分析,共识别24748例酒精性肝硬化患者,5417例符合匹配条件,采用倾向评分1:2匹配他汀使用者与非使用者,最终匹配队列744例。他汀使用者死亡率为每1000人年88(95%CI 73-105),非使用者为127(95%CI 114-141),HR为0.57(95%CI 0.45-0.71)。更规律的他汀处方模式与更低死亡风险相关。

要点

  • 酒精性肝硬化患者中使用他汀与死亡率降低相关,HR为0.57(95%CI 0.45-0.71)。
  • 他汀使用者死亡率每1000人年88(95%CI 73-105),非使用者每1000人年127(95%CI 114-141)。
  • 更规律的他汀处方领取模式与更低死亡风险相关。

核心结论

  • 研究结果显示,规律使用他汀与酒精性肝硬化患者死亡率降低相关。

研究设计与样本

  • 回顾性病例队列分析,基于丹麦登记数据1995年至2014年,索引日期为肝硬化诊断时间(ICD-10:K703),采用倾向评分匹配他汀使用者与非使用者比例1:2,共识别24748例酒精性肝硬化患者,5417例符合匹配条件,最终匹配队列744例。

主要发现

  • 匹配队列平均年龄56岁(SD 10),女性占36%,他汀使用患病率为15%。
  • 他汀使用者死亡率为每1000人年88(95%CI 73-105),非他汀使用者为每1000人年127(95%CI 114-141),HR为0.57(95%CI 0.45-0.71)。
  • 更规律的他汀处方领取模式与更低死亡风险相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reports have indicated that the use of statins may ameliorate the course of cirrhosis. AIM: To determine the relationship between use of statins and mortality rate in patients with cirrhosis. METHODS: We did a retrospective case-cohort analysis based on data from the Danish registers from the period 1995 through 2014. Index date was time of diagnosis of cirrhosis (ICD-10: K703) and cohort entry depended on whether the patient was statin user or not. We used propensity score matching with a statin:non-statin ratio of 1:2. We included the exposure to statins (ATC classification C10AA) from the index date until death or end of follow-up based on prescription claims. Use of statins based on at least two statin claims as well as the longitudinal pattern over time of statin claims was tested against mortality. The main outcome was mortality rate. RESULTS: A total of 24 748 patients with alcoholic cirrhosis were identified and 5417 were eligible for matching. The mean age was 56 (SD 10) years and 36% were females. The prevalence of use of statins was 15%. We included 744 in the matched cohort. Mortality rates were 88 (95% CI 73-105) per 1000 years for patients using statin and 127 (95% CI 114-141) for non-statin patients with a HR of 0.57 (95% CI 0.45-0.71). A more regular pattern of statin claims was related to a lower risk of death. CONCLUSIONS: Our results showed an association between regular use of statins and reduced mortality in patients with alcoholic cirrhosis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Bang UC, Benfield T, Bendtsen F, et al. Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study. Aliment Pharmacol Ther. 2017. PMID: 28880449. doi:10.1111/apt.14243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。